Yigal Nochomovitz
Stock Analyst at Citigroup
(2.27)
# 2,577
Out of 4,846 analysts
298
Total ratings
37.45%
Success rate
-1.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Buy | $49 → $41 | $19.14 | +114.21% | 15 | May 22, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $215 → $155 | $125.36 | +23.64% | 5 | May 16, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $7.33 | +29.60% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $3.85 | +159.74% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $17.73 | +97.46% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $28.93 | +62.46% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $11.64 | +63.23% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $20.15 | +172.95% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $10.98 | +282.69% | 8 | Mar 4, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $5.59 | +347.23% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $36.95 | +121.92% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $7.42 | +344.74% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $58.32 | +66.32% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.36 | +2,147.82% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $0.97 | +515.45% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $10.03 | +169.19% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.05 | +91.39% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $22.12 | +62.75% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $21.22 | +173.33% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $1.55 | +1,319.35% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.40 | +903.58% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.29 | +313.94% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $9.22 | +312.15% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $8.45 | +65.78% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.79 | +12.04% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $31.18 | +111.67% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $12.78 | +275.73% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.38 | +357.14% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $2.11 | +279.15% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.05 | -67.26% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $8.00 | +337.50% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $36.15 | +267.91% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.62 | +1,187.00% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.71 | +744.71% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.49 | +973.83% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.29 | +675.19% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.74 | +2,065.38% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.15 | +457.31% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.29 | - | 14 | Sep 28, 2021 |
Apellis Pharmaceuticals
May 22, 2025
Maintains: Buy
Price Target: $49 → $41
Current: $19.14
Upside: +114.21%
Krystal Biotech
May 16, 2025
Maintains: Neutral
Price Target: $215 → $155
Current: $125.36
Upside: +23.64%
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.33
Upside: +29.60%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.85
Upside: +159.74%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $17.73
Upside: +97.46%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $28.93
Upside: +62.46%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $11.64
Upside: +63.23%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $20.15
Upside: +172.95%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $10.98
Upside: +282.69%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.59
Upside: +347.23%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $36.95
Upside: +121.92%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $7.42
Upside: +344.74%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $58.32
Upside: +66.32%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.36
Upside: +2,147.82%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $0.97
Upside: +515.45%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $10.03
Upside: +169.19%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.05
Upside: +91.39%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $22.12
Upside: +62.75%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $21.22
Upside: +173.33%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $1.55
Upside: +1,319.35%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.40
Upside: +903.58%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.29
Upside: +313.94%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $9.22
Upside: +312.15%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $8.45
Upside: +65.78%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.79
Upside: +12.04%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $31.18
Upside: +111.67%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $12.78
Upside: +275.73%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.38
Upside: +357.14%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $2.11
Upside: +279.15%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.05
Upside: -67.26%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $8.00
Upside: +337.50%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $36.15
Upside: +267.91%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.62
Upside: +1,187.00%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.71
Upside: +744.71%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.49
Upside: +973.83%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.29
Upside: +675.19%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.74
Upside: +2,065.38%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.15
Upside: +457.31%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.29
Upside: -